Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

2.6K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.6K
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

52
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

44
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do "Developing" Countries Become "Developed"? Lessons from <italic>Helicobacter pylori</italic> Infection Recurrence Rate after Eradication.

Digestive diseases (Basel, Switzerland)·2026
Same author

Can Video Capsule Endoscopy Replace Biopsy in the Diagnosis of Celiac Disease?

The Israel Medical Association journal : IMAJ·2026
Same author

[Treatment Safety and Risk Management in Medicine Taught in Medical Schools in Israel, Compared to the U.S.]

Harefuah·2026
Same author

Esophageal motility disorders after COVID-19 infection.

Scientific reports·2025
Same author

Freezing while preserving achievements: suspending quality indicators in healthcare, Israel's experience.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2025
Same author

Comparison of Outcomes of Chronic Obstructive Pulmonary Disease Patients Hospitalized in Hospital-at-Home vs. In-hospital Settings: A Systematic Review and Meta-analysis.

The Israel Medical Association journal : IMAJ·2025
Same journal

Trembling technique for improving colonic adenoma detection rate by enhancing mucosal exposure during withdrawal: A prospective, non-randomized single center study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Consensus recommendations for the management of H. pylori in Egypt: 2026 report.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
11:17

Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor

Published on: February 10, 2014

11.2K

Gastric barrier function and toxic damage.

Yaron Niv1, Marko Banić

  • 1Department of Gastroenterology, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.

Digestive Diseases (Basel, Switzerland)
|April 16, 2014
PubMed
Summary
This summary is machine-generated.

The gastric epithelium protects the body from ingested toxins. Its integrity relies on defense mechanisms, with treatments targeting H. pylori and NSAID-induced ulcers.

More Related Videos

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
05:14

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

12.2K
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

7.7K

Related Experiment Videos

Last Updated: May 1, 2026

Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
11:17

Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor

Published on: February 10, 2014

11.2K
Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
05:14

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

12.2K
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

7.7K

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Immunology

Background:

  • The gastric epithelium forms a critical barrier against luminal toxins like alcohol, NSAIDs, and H. pylori.
  • Gastric mucosal integrity is maintained by complex defense mechanisms including acid secretion, blood flow, and cell renewal.
  • The gastric mucosa also plays a role in the immune system through gut-associated lymphoid tissue.

Purpose of the Study:

  • To review the defense mechanisms of the gastric epithelium.
  • To discuss factors affecting gastric barrier integrity.
  • To outline current treatment strategies for gastric damage.

Main Methods:

  • Literature review of gastric physiology and pathology.
  • Analysis of defense mechanisms mediated by prostaglandins, nitric oxide, and neuropeptides.
  • Examination of the role of the central nervous system and immune components.

Main Results:

  • Gastric defense involves multiple integrated pathways including mucosal blood flow, mucus secretion, and cell turnover.
  • Prostaglandins, nitric oxide, growth factors, and calcitonin gene-related peptide are key mediators.
  • Adrenal glucocorticoids and the central nervous system significantly influence gastroprotection.

Conclusions:

  • Gastric barrier function is crucial for preventing damage from various agents.
  • Effective treatment for gastric dysfunction requires understanding underlying pathophysiological mechanisms.
  • Current management focuses on H. pylori eradication and preventing NSAID/aspirin-induced ulcers.